December 14, 2016 / 1:35 PM / in 7 months

BRIEF-Medivir says fusion inhibitor MIV-323 enters non-clinical development

1 Min Read

Dec 14 (Reuters) - Medivir AB

* Medivir's fusion inhibitor for the treatment of respiratory syncytial virus infection, MIV-323, enters non-clinical development Source text for Eikon: Further company coverage: (Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below